StockData
Illumina, Inc. logo

Illumina, Inc.

ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 30, 2026Score 14/308% above fair value
$192.82−7.84 (-3.90%)

Close on Nov 20, 2026Market cap $29.15BP/E 33.1Yield –

Illumina Total Microarray Revenue by Year

Total Microarray Revenue ($M) ($M)

Illumina Total Microarray Revenue: $358M in FY2025, down 5.5% from a year earlier. That is the lowest of the 10 years on record here.

Latest, FY2025
358
Period ended Dec 31, 2025
Change on a year earlier
-5.5%
379 in FY2024
History
10 years
Since FY2016
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Illumina Form 10-K for FY2025 (filed 2026-02-12) ↗

Total product plus service and other revenue from the Microarray portfolio (Q4 = FY − 9M).

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up total Microarray Revenue

Cite this data

StockData. (2026). Illumina Total Microarray Revenue ($M), annual FY2016–FY2025 [Data set]. Compiled from Illumina SEC filings and investor materials. https://stockdatahq.com/stocks/ilmn/kpis/array-total-rev

See every metric in the Illumina KPI table. Data updated Nov 9, 2026.

See a number that looks wrong?